Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(100.0%)
4Total
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01528852Phase 3Completed

Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis

Role: collaborator

NCT00980421Phase 3Unknown

Safety of Various Mode of Delivery of Iron Supplement on Iron Toxicity Markers in Preschool Children

Role: lead

NCT00980733Phase 3Unknown

Efficacy of Micronutrient Fortified Yoghurt in School Children for Health Benefits

Role: lead

NCT00255385Phase 3Completed

Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk

Role: collaborator

All 4 trials loaded